Moderna Board Member Resigns To Avoid Conflict of Interest in Vaccine Trial
Click the image below to enlarge the infographic.
- A member of Moderna's board of directors has resigned to avoid “potential or even apparent conflict of interest” as the drug maker enters phase three of its coronavirus vaccine trials
- Dr. Elizabeth Nabel resignation was effective immediately after five years of sitting on the company's board of directors, Moderna said in a statement Thursday
- Nabel is the president of Brigham and Women's Hospital, which is one of the study sites involved in phase three of the trial
- Moderna began its phase three human trial of the coronavirus vaccine candidate on Monday after early trial results showed effectiveness and safety of the vaccine
- The company said it had already vaccinated several hundred people within the first few days of the trial